▶ Watch on YouTube
Health

Propranolol lot recalled in the U.S. over possible metal contamination

2026-11-17 · Nuevo Día
Propranolol lot recalled in the U.S. over possible metal contamination

Drugmaker Breckenridge Pharmaceutical has recalled a lot of 60-milligram extended-release propranolol capsules in the United States over possible contamination with metal particles, the company said on November 16.

The affected lot is PK25110035, expiring in May 2029, distributed between October 26 and November 4 to wholesalers and pharmacies across the country. The company warned that metal fragments could cause injuries to the mouth, esophagus, stomach or intestines.

The medicine, made by Adare Pharma Solutions, is used to treat high blood pressure, reduce episodes of chest pain, prevent some migraines and treat certain cases of hypertrophic cardiomyopathy. The recall, voluntary and carried out with the knowledge of the Food and Drug Administration (FDA), affects only that lot and that product: it is not a general recall of propranolol.

People who use this medicine should check the lot number on their package and, if it matches the recalled lot, ask their pharmacy or doctor how to proceed. The product's national code is 51991-817-01 and it is sold in bottles of 100 capsules.

Photo: El Folio

Source: El Folio

← More news in Health · Leer en español